243 related articles for article (PubMed ID: 34217892)
1. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells.
Qiu W; Guo X; Li B; Wang J; Qi Y; Chen Z; Zhao R; Deng L; Qian M; Wang S; Zhang Z; Guo Q; Zhang S; Pan Z; Zhao S; Xue H; Li G
Mol Ther; 2021 Dec; 29(12):3449-3464. PubMed ID: 34217892
[TBL] [Abstract][Full Text] [Related]
2. Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways.
Guo X; Qiu W; Wang J; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Guo Q; Xu J; Xue H; Li G
Int J Cancer; 2019 Jun; 144(12):3111-3126. PubMed ID: 30536597
[TBL] [Abstract][Full Text] [Related]
3. The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs.
Qi Y; Jin C; Qiu W; Zhao R; Wang S; Li B; Zhang Z; Guo Q; Zhang S; Gao Z; Zhao S; Pan Z; Fan Y; Chen Z; Wang H; Xu J; Deng L; Ni S; Wang J; Xue H; Xue F; Li G
Cell Death Dis; 2022 May; 13(5):426. PubMed ID: 35501306
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop.
Qiu W; Guo Q; Guo X; Wang C; Li B; Qi Y; Wang S; Zhao R; Han X; Du H; Zhao S; Pan Z; Fan Y; Wang Q; Gao Z; Li G; Xue H
J Nanobiotechnology; 2023 Jul; 21(1):233. PubMed ID: 37481646
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
Li M; Xu H; Qi Y; Pan Z; Li B; Gao Z; Zhao R; Xue H; Li G
Oncogene; 2022 Oct; 41(41):4618-4632. PubMed ID: 36085418
[TBL] [Abstract][Full Text] [Related]
7. G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition.
Wang Y; Liu H; Zhang Z; Bian D; Shao K; Wang S; Ding Y
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364932
[TBL] [Abstract][Full Text] [Related]
8. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
9. Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment.
Liang L; Xu X; Li J; Yang C
Front Immunol; 2022; 13():883683. PubMed ID: 35634311
[TBL] [Abstract][Full Text] [Related]
10. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
Shokati E; Safari E
Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12.
Bao Z; Zhang N; Niu W; Mu M; Zhang X; Hu S; Niu C
Cell Death Dis; 2022 Aug; 13(8):725. PubMed ID: 35986010
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.
Guo Q; Fan Y; Wang Q; Li B; Qiu W; Qi Y; Pan Z; Zhang S; Zhao S; Yang K; Xu H; Li M; Gao Z; Xu J; Wang H; Wang S; Tang Q; Qiu J; Guo X; Deng L; Zhang P; Zhao R; Xue H; Wang C; Li G
Cell Death Dis; 2023 Feb; 14(2):147. PubMed ID: 36810326
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes.
Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G
Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089
[TBL] [Abstract][Full Text] [Related]
16. miR-3184-3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2-like macrophage polarization.
Xu H; Li M; Pan Z; Zhang Z; Gao Z; Zhao R; Li B; Qi Y; Qiu W; Guo Q; Zhang S; Fan Y; Zhao S; Wang S; Guo X; Deng L; Xue H; Li G
Cancer Sci; 2022 Aug; 113(8):2668-2680. PubMed ID: 35411604
[TBL] [Abstract][Full Text] [Related]
17. miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
Zhang X; Li F; Tang Y; Ren Q; Xiao B; Wan Y; Jiang S
Oncogene; 2020 Oct; 39(40):6354-6369. PubMed ID: 32855524
[TBL] [Abstract][Full Text] [Related]
18. Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression.
Deng SZ; Lai MF; Li YP; Xu CH; Zhang HR; Kuang JG
Cancer Gene Ther; 2020 Apr; 27(3-4):203-215. PubMed ID: 30728448
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
Gao F; Xu Q; Tang Z; Zhang N; Huang Y; Li Z; Dai Y; Yu Q; Zhu J
J Transl Med; 2022 Aug; 20(1):346. PubMed ID: 35918733
[TBL] [Abstract][Full Text] [Related]
20. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway.
Xu X; Liu Y; Li Y; Chen H; Zhang Y; Liu J; Deng S; Zheng Y; Sun X; Wang J; Chen T; Huang M; Ke Y
J Exp Clin Cancer Res; 2021 Jan; 40(1):16. PubMed ID: 33407703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
